Phase II Study of Oral S-1 and Concurrent Radiotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer-Reference-Cited by-同舟云学术

Phase II Study of Oral S-1 and Concurrent Radiotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer

Published:2011-05 Issue:1 Volume:80 Page:119-125
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Sudo Kentaro,Yamaguchi Taketo,Ishihara Takeshi,Nakamura Kazuyoshi,Hara Taro,Denda Tadamichi,Tawada Katsunobu,Imagumbai Toshiyuki,Araki Hitoshi,Sakai Mitsuhiro,Hatano Kazuo,Kawakami Hiroyuki,Uno Takashi,Ito Hisao,Yokosuka Osamu

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference32 articles.

1. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer;Moertel;Lancet,1969

2. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group;Moertel;Cancer,1981

3. Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group;Treatment of locally unresectable carcinoma of the pancreas;J Natl Cancer Inst,1988

4. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma;Ishii;Cancer,1997

5. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators;Shirasaka;Anticancer Drugs,1996

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes of Proton Beam Therapy for Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Retrospective Study;Advances in Radiation Oncology;2024-10

2. Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma;World Journal of Clinical Oncology;2024-07-24

3. Neoadjuvant therapy with intensity‐modulated radiotherapy combined with S‐1 for borderline‐resectable pancreatic cancer;Asia-Pacific Journal of Clinical Oncology;2024-05-21

4. Comparison of acute gastrointestinal toxicities between 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy including prophylactic regions in chemoradiotherapy with S-1 for pancreatic cancer—importance of dose volume histogram parameters in the stomach as the predictive factors-;Journal of Radiation Research;2022-08-20

5. Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy;Frontiers in Oncology;2022-01-06